VOL 10 | ISSUE 06 | 2019
20 CEO s
Dr. Bassam Damaj Proven Track Record of Doing Commercial and Partnership Deals, Building a Rich Pipeline and Turning Around Biotech and Pharma Companies
VOL 10 | ISSUE 06 | 2019
20 CEO s
Dr. Bassam Damaj Proven Track Record of Doing Commercial and Partnership Deals, Building a Rich Pipeline and Turning Around Biotech and Pharma Companies